HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal Cancer
2019 · The Oncologist · 165 citations
https://doi.org/10.1634/theoncologist.2018-0785
L
Luca Porcu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
225
Papers
3.4K
Citations
31
h-index
76
i10-index
Luca Porcu is an academic researcher from Mario Negri Institute for Pharmacological Research. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Cancer Immunotherapy and Biomarkers & Colorectal Cancer Treatments and Studies. The author has an h-index of 31, co-authored 192 publications.
ORCID: 0000-0002-0911-9775Papers by this author
worksAssessment of proportional hazard assumption in aggregate data: a systematic review on statistical methodology in clinical trials using time-to-event endpoint
2018 · British Journal of Cancer · 75 citations
https://doi.org/10.1038/s41416-018-0302-8
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC
2024 · Journal of Thoracic Oncology · 63 citations
https://doi.org/10.1016/j.jtho.2024.03.010
Cancer-related fatigue and depression: a monocentric, prospective, cross-sectional study in advanced solid tumors
2022 · ESMO Open · 34 citations
https://doi.org/10.1016/j.esmoop.2022.100457
CXCL1-CXCR1/2 signaling is induced in human temporal lobe epilepsy and contributes to seizures in a murine model of acquired epilepsy
2021 · Neurobiology of Disease · 32 citations
https://doi.org/10.1016/j.nbd.2021.105468
Diagnostic and prognostic values of PBMC proteins in amyotrophic lateral sclerosis
2020 · Neurobiology of Disease · 30 citations
https://doi.org/10.1016/j.nbd.2020.104815
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat